Performance Standards for Ionizing Radiation Emitting Products; Fluoroscopic Equipment; Correction; Confirmation of Effective Date, 43320 [2015-17930]

Download as PDF 43320 Federal Register / Vol. 80, No. 140 / Wednesday, July 22, 2015 / Rules and Regulations 29. In supplement No. 1 to part 774, ECCN 2E994 is amended by revising the ‘‘Control(s)’’ paragraph to read as follows: ■ 2E994 ‘‘Technology’’ for the ‘‘use’’ of portable electric generators controlled by 2A994. License Requirements * * * * * Control(s): AT applies to entire entry. A license is required for items controlled by this entry to Iran and North Korea for anti-terrorism reasons. The Commerce Country Chart is not designed to determine licensing requirements for this entry. See part 746 of the EAR for additional information on Iran. See § 742.19 of the EAR for additional information on North Korea. * * * * * ECCN 4A001—[Amended] 30. In supplement No. 1 to part 774, ECCN 4A003 is amended by adding the phrase ‘‘or E:2’’ immediately following the phrase ‘‘Country Group E:1’’ in the note that immediately follows the License Requirements table. ■ Dated: July 17, 2015. Kevin J. Wolf, Assistant Secretary for Export Administration. the accuracy of the regulations. This document confirms the effective date of the direct final rule. DATES: Effective date of the final rule published in the Federal Register of April 13, 2015 (80 FR 19530), confirmed: August 26, 2015. FOR FURTHER INFORMATION CONTACT: Scott Gonzalez, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 4641, Silver Spring, MD 20993–0002, 301–796–5889. SUPPLEMENTARY INFORMATION: In the Federal Register of April 13, 2015 (80 FR 19530), FDA solicited comments concerning the direct final rule for a 75day period ending June 29, 2015. We stated that the effective date of the direct final rule would be on August 26, 2015, 30 days after the end of the comment period, unless FDA received any significant adverse comment during the comment period. FDA did not receive any significant adverse comments. Authority: 21 U.S.C. 351, 352, 360e–360j, 360hh–360ss, 371, 381. Accordingly, the amendment issued thereby is effective. Dated: July 16, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–17930 Filed 7–21–15; 8:45 am] BILLING CODE 4164–01–P [FR Doc. 2015–17981 Filed 7–21–15; 8:45 am] BILLING CODE 3510–33–P DEPARTMENT OF VETERANS AFFAIRS DEPARTMENT OF HEALTH AND HUMAN SERVICES 38 CFR Parts 17, 39, 48, 49, 51, 52, 53, 59, 61, 62, and 64 Food and Drug Administration RIN 2900–AP22 21 CFR Part 1020 [Docket No. FDA–2015–N–0828] Performance Standards for Ionizing Radiation Emitting Products; Fluoroscopic Equipment; Correction; Confirmation of Effective Date Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards; Updating References AGENCY: AGENCY: Food and Drug Administration, HHS. Direct final rule; confirmation of effective date. ACTION: The Food and Drug Administration (FDA or we) is confirming the effective date of August 26, 2015, for the direct final rule that appeared in the Federal Register of April 13, 2015. The direct final rule amends a Federal performance standard for ionizing radiation to correct a drafting error regarding fluoroscopic equipment measurement. We are taking this action to ensure clarity and improve Lhorne on DSK7TPTVN1PROD with RULES SUMMARY: VerDate Sep<11>2014 15:06 Jul 21, 2015 Jkt 235001 ACTION: Department of Veterans Affairs. Final rule. The Department of Veterans Affairs (VA) is amending its regulations with updated citations and references to Office of Management and Budget (OMB) authorities for Federal grant programs. OMB has issued final guidance, located in Title 2 of the Code of Federal Regulations (CFR), which streamlines and supersedes requirements previously found in various OMB Circulars. VA has adopted OMB’s guidance, and this rule replaces the obsolete OMB references in VA’s regulations. SUMMARY: This final rule is effective July 22, 2015. DATES: PO 00000 Frm 00020 Fmt 4700 Sfmt 4700 FOR FURTHER INFORMATION CONTACT: Brian McCarthy, Office of Regulatory and Administrative Affairs (10B4), Veterans Health Administration, Department of Veterans Affairs, 810 Vermont Ave. NW., Washington, DC 20420, (202) 461–6345. (This is not a toll-free telephone number.) SUPPLEMENTARY INFORMATION: The Office of Management and Budget (OMB) is streamlining the Federal government’s guidance on Administrative Requirements, Cost Principles, and Audit Requirements for Federal awards. In a document published in the Federal Register on December 26, 2013 (78 FR 78590), OMB adopted final guidance, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), that supersedes and streamlines requirements from OMB Circulars A–21, A–87, A–110, and A–122 (which have been placed in OMB guidances); Circulars A–89, A–102, and A–133; and the guidance in Circular A–50 on Single Audit Act follow-up. The final guidance is located in title 2 of the Code of Federal Regulations (CFR). On December 19, 2014, OMB published a joint interim final rule in the Federal Register (79 FR 75871). OMB made technical corrections to the Uniform Guidance, and Federal awarding agencies, including VA, implemented the guidance in their respective chapters of title 2 of the CFR. VA amended title 2 of the CFR to add part 802. Section 802.101 of title 2 CFR now provides, ‘‘The Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards set forth in 2 CFR part 200 shall apply to the Department of Veterans Affairs.’’ VA also removed parts 41 and 43 from title 38 CFR. Those parts codified OMB Circulars that were superseded by the Uniform Guidance. Because of these changes, existing references in VA’s regulations to the superseded OMB guidance documents and to parts 41 and 43 are obsolete. Accordingly, we are amending various VA regulations located in 38 CFR parts 17, 39, 48, 51, 52, 53, 59, 61, 62, and 64 to replace the obsolete references with references to the current authority. For the same reason, we are removing part 49 of title 38 CFR, which codified OMB Circular A–110, and amending VA’s regulations referencing part 49 to reference 2 CFR part 200 instead. Administrative Procedure Act The Secretary of Veterans Affairs finds there is good cause under the provisions of 5 U.S.C. 553(b)(B) and (d)(3) to publish this rule without prior E:\FR\FM\22JYR1.SGM 22JYR1

Agencies

[Federal Register Volume 80, Number 140 (Wednesday, July 22, 2015)]
[Rules and Regulations]
[Page 43320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-17930]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 1020

[Docket No. FDA-2015-N-0828]


Performance Standards for Ionizing Radiation Emitting Products; 
Fluoroscopic Equipment; Correction; Confirmation of Effective Date

AGENCY: Food and Drug Administration, HHS.

ACTION: Direct final rule; confirmation of effective date.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is confirming the 
effective date of August 26, 2015, for the direct final rule that 
appeared in the Federal Register of April 13, 2015. The direct final 
rule amends a Federal performance standard for ionizing radiation to 
correct a drafting error regarding fluoroscopic equipment measurement. 
We are taking this action to ensure clarity and improve the accuracy of 
the regulations. This document confirms the effective date of the 
direct final rule.

DATES: Effective date of the final rule published in the Federal 
Register of April 13, 2015 (80 FR 19530), confirmed: August 26, 2015.

FOR FURTHER INFORMATION CONTACT: Scott Gonzalez, Center for Devices and 
Radiological Health, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 66, Rm. 4641, Silver Spring, MD 20993-0002, 301-796-5889.

SUPPLEMENTARY INFORMATION: In the Federal Register of April 13, 2015 
(80 FR 19530), FDA solicited comments concerning the direct final rule 
for a 75-day period ending June 29, 2015. We stated that the effective 
date of the direct final rule would be on August 26, 2015, 30 days 
after the end of the comment period, unless FDA received any 
significant adverse comment during the comment period. FDA did not 
receive any significant adverse comments.

    Authority: 21 U.S.C. 351, 352, 360e-360j, 360hh-360ss, 371, 381. 
Accordingly, the amendment issued thereby is effective.

    Dated: July 16, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-17930 Filed 7-21-15; 8:45 am]
BILLING CODE 4164-01-P